首页> 外文OA文献 >A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer

【2h】

A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer

机译：E1A在乳腺癌中EGFR-TKI治疗组合治疗的新型应用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chih-Ming Su; Ting-Yu Chang; Hui-Ping Hsu; Hui-Huang Lai; Jie-Ning Li; Yu-Jhen Lyu; Kuang-Tai Kuo; Ming-Te Huang; Jen-Liang Su; Pai-Sheng Chen;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation [J] . Yan Xiangtao, Wang Huijuan, Li Peng, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第期

机译：单独或与低丰度突变的先进非小细胞肺癌（NSCLC）组合单独使用表皮生长因子受体 - 酪氨酸激酶抑制剂（EGFR-TKI）的疗效。
2. Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer [J] . Qi Huiwei, Jiang Sen, Yu Dong, Medical oncology . 2015,第12期

机译：晚期EGFR突变非小细胞肺癌患者继续进行EGFR-TKI治疗与超选择性动脉灌注化疗相结合，超越疾病进展
3. Interview for Breast Cancer Management with Dr David Montgomery: marketing authorization for Pfizer's metastatic breast cancer treatment, palbociclib (Ibrance?) in combination with endocrine therapy [J] . David Montgomery Breast cancer management. . 2016,第3a4期

机译：采访乳腺癌管理与David Montgomery博士：普遍促销乳腺癌治疗的营销授权，Palbociclib（Ibrance？）与内分泌治疗组合
4. Polymer-Drug Conjugates as platforms for combination therapy in the treatment of hormone-dependent breast cancer [C] . C. Deladriere. E. Masia, F. Greco, R. Lucas, Annual meeting exposition of the Controlled Release Society . 2011

机译：聚合物-药物结合物可作为联合疗法治疗激素依赖性乳腺癌的平台
5. Effects of EGCG and DAC Combinational Treatment on Treating Triple Negative Breast Cancer and Aiding Immune Checkpoint Blockage Therapies [D] . Wang, Zixu. 2019

机译：EGCG和DAC组合治疗对治疗三重阴性乳腺癌的影响及辅助免疫检查点梗阻疗法
6. A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer [O] . Chih-Ming Su, Ting-Yu Chang, Hui-Ping Hsu, 2016

机译：E1A在EGFR-TKI联合治疗乳腺癌中的新应用
7. PCN4 Sequential Combination of Chemotherapy With Egfr-Tki As The First-Line Treatment for Unselected Patients With Advanced Non-Small Cell Lung Cancer: Systematic Review of Randomized Controlled Trials [O] . Li X, Tang X, Li Y, 2014

机译：PCN4序贯化疗联合Egfr-Tki作为未选患者的晚期非小细胞肺癌的一线治疗：随机对照试验的系统评价
8. Use of Combination Thermal Therapy & Radiation in Breast-Conserving Treatment of Extensive Intraductal Breast Cancer (Breast Cancer) [R] . Svensson, G. 1999

机译：联合热疗和放射治疗广泛导管内乳腺癌（乳腺癌）的应用

A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅